Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
The proposed research deals with several aspects of the central modulation
of somatosensation. One of the main goals is to identify the
neurotransmitter of cortical neurons at the origin of the descending
pathways to the somatosensory thalamus, the dorsal column nuclei and the
spinal cord in rats. Available evidence suggests that glutamate may be
involved in these neurons and we will employ an immunocytochemical approach
combined with the retrograde transport of dyes to verify this.
Double-labeling immunocytochemistry will be also employed to investigate
whether some of the peptides known to be present in non-pyramidal cortical
neurons co-localize with glutamergic neurons in layer VI.
We also wish to investigate whether modulation of VB activity in cats by
the cortex and other subcortical centers (e.g. raphe nuclei, periaqueductal
gray, etc.) is primarily mediated via direct contacts upon intrinsic GABA -
ergic neurons. Combination of immunocytochemistry against glutamic acid
decarboxylase (GAD) and anterograde tracing techniques will be employed at
the electron microscopical level. This part of the planned research will
elucidate mechanisms presumably involved in some basic thalamic functions
and will establish a solid basis for further insights in how input from
different centers may affect the activity of VB neurons.
As a third main goal, we'll try to answer whether GAD positive neurons in
cat's VB contain peptides that are believed to be involved in some form of
control of neurotransmission. The rationale for this part of the research
lies mainly in the demonstration that GABA - ergic neurons, e.g. in the
cortex, may express other molecular markers. Furthermore species
differences in the presence of GABA - ergic neurons and co-localisation of
other markers may reflect increasing elaboration and complexity of
functional features of thalamic nuclei.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
608195277
UEI
D3LHU66KBLD5
Project Start Date
01-April-1980
Project End Date
31-March-1993
Budget Start Date
01-April-1987
Budget End Date
31-March-1988
Project Funding Information for 1987
Total Funding
$123,549
Direct Costs
$85,928
Indirect Costs
$37,621
Year
Funding IC
FY Total Cost by IC
1987
National Institute of Neurological Disorders and Stroke
$123,549
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS016264-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS016264-08
Patents
No Patents information available for 5R01NS016264-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS016264-08
Clinical Studies
No Clinical Studies information available for 5R01NS016264-08
News and More
Related News Releases
No news release information available for 5R01NS016264-08
History
No Historical information available for 5R01NS016264-08
Similar Projects
No Similar Projects information available for 5R01NS016264-08